Navigation Links
CuraGen Appoints Clinical Oncologist as VP of Medical Development
Date:9/26/2007

BRANFORD, Conn., Sept. 26 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that Ronit Simantov, M.D., has joined CuraGen as Vice President of Medical Development.

Dr. Simantov is a seasoned and accomplished clinical oncologist with experience obtained in both pharmaceutical and academic positions. In her previous position at Bayer Healthcare Pharmaceuticals, Dr. Simantov played a key role in the successful clinical development, registration, and launch of Nexavar(R) (sorafenib), which was approved by the FDA in 2005. During her academic career, Dr. Simantov conducted research into the modulation of angiogenesis in cancer, and has published extensively in peer-reviewed journals.

"We believe that Ronit has the right expertise to assist us in the evaluation of the data being generated from our three clinical oncology programs, and to support the preparations being made to potentially transition one or more of these products into Phase III during 2008," commented Timothy Shannon, M.D., President and Chief Executive Officer of CuraGen. "Her addition to the team currently in place provides CuraGen with a talented, and very experienced, group of individuals who have a history of successfully bringing products through clinical development and onto market."

Prior to joining CuraGen, Dr. Simantov held positions of increasing responsibility at Bayer Healthcare Pharmaceuticals from June 2003 through August 2007, and was most recently Director, Global Clinical Leader, Oncology during which she was responsible for the global development of Nexavar(R) in non-small cell lung cancer (NSCLC) and medical lead for regulatory sub
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Research and Markets has announced the addition of ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... to determine the size of a particle in a material ... the size of particles as it can affect the functionality ... determine the behavior and nature of a material, and for ...
(Date:7/26/2014)... July 26, 2014 Canada Endoscopy ... market data on the Canada Endoscopy Visualization Systems ... US dollars, volume (in units) and average prices ... Endoscopy Visualization Systems, Mid-Range Endoscopy Visualization Systems and ... at http://www.marketresearchreports.biz/analysis/213254 . , The report also ...
(Date:7/25/2014)... Amgen (NASDAQ: AMGN ) announced ... per share dividend for the third quarter of 2014. ... to all stockholders of record as of the close ... About Amgen Amgen is committed to unlocking the potential ... discovering, developing, manufacturing and delivering innovative human therapeutics. This ...
(Date:7/25/2014)... from the University of Leicester has furthered our ... potential to create new materials using nanosized ,building ... in the prestigious academic journal Physical Review ... examine in rich detail the structure and internal ... acetylene molecule and a single helium atom. , ...
Breaking Biology Technology:Global Particle Size Analysis Market 2014-2018 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3
... with live study setup and launch..., WAYLAND, ... in bio-pharmaceutical clinical trials software, announces the,launch of ... studies. Trident,s unique parameter driven + custom pluggable ... to deliver a new era,of needed scalability, productivity, ...
... March 20 NexGen,Biofuels Ltd. (OTC:NXGNF) announced today ... shares have been approved for quotation on the,OTC-Bulletin ... a development stage company that is currently seeking ... blending assets in,the United States., For More ...
... Therapies Will Not Match, the Current Gold-Standard ... According to a New Report ... Decision Resources, one of the,world,s leading research and advisory ... drug Zactima from AstraZeneca,will earn 4.7 percent patient share ...
Cached Biology Technology:Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 2Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 3AstraZeneca's Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016 2
(Date:7/28/2014)... A study of juvenile rat brain cells suggests that ... the connections between brain cells are temporary. , The ... PLOS ONE , was conducted by biologists at ... Medical College in New York in response to concerns, ... decade, that exposing children to general anesthetics may increase ...
(Date:7/28/2014)... areas of the Earth that are high priorities for ... is particularly vulnerable, as it has the lowest fraction ... any continent in ,refugia, areas of biological diversity ... relatively constant during times of great environmental change. The ... Scandinavia and Scotland. , The biggest refugia are ...
(Date:7/28/2014)... tool that can help advance the genetic engineering ... bioenergy, has been developed by researchers with the ... (JBEI), a multi-institutional partnership led by Lawrence Berkeley ... developed an assay that enables scientists to identify ... critical components in the biosynthesis of plant cell ...
Breaking Biology News(10 mins):Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3Study finds Europe's habitat and wildlife is vulnerable to climate change 2How sweet it is 2How sweet it is 3
... clinical research is being done, warns a senior doctor ... is failing patients and clinicians by neglecting this vital ... information that doctors need to diagnose and treat patients ... field of neurology alone, many examples exist where a ...
... and Geoff Garnett (of Imperial College London) suggests that ... controlled through antiretroviral drugs alone, even if universal access ... the open-access international medical journal PLoS Medicine, without additional ... about safe sex, access to drugs is likely to ...
... causes mice to develop the metabolic syndrome, researchers at ... at OHSU, the University of Texas Medical Branch and ... lack the gene encoding the DNA repair enzyme NEIL1 ... twice the weight of their normal counterparts. The mice, ...
Cached Biology News:Access to antiretrovirals unlikely to reduce HIV infection rates 2Removing DNA repair gene causes metabolic syndrome 2Removing DNA repair gene causes metabolic syndrome 3
... Systems provide fast and reliable automation ... and drug development laboratories. Staccato Custom ... specifications, providing solutions that are tailored ... Custom Systems are controlled with either ...
... Not treated (or medium binding) polystyrene ... binds biomolecules through passive interactions,• Is ... large molecules, such as antibodies, that ... interact with the surface,• Binding capacity ...
... tabs • Reusable, press-to-seal gasket and ... assembled and disassembled for hybridizing and imaging ... thickness with up to a 13 mm ... slide. Minimize specimen handling, eliminate evaporation and ...
...
Biology Products: